SCHEMBL28359374

SCHEMBL28359374

CC(C)(C)OC(=O)N1CC(Cn2cc(Nc3cc(-c4c(F)cccc4F)nnc3C(N)=O)cn2)C1

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 9/20 0.44
▸ JAK1 P23458 9/20 0.44
▸ JAK3 P52333 7/20 0.44
▸ TYK2 P29597 5/20 0.44
▸ BTK Q06187 2/20 0.35
▸ ALOX5AP P20292 2/20 0.34
▸ FEN1 P39748 2/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ SCD O00767 1/20 0.34
▸ SCD5 Q86SK9 1/20 0.34
▸ RORC P51449 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29552317 0.93 TYK2 (0.36) JAK2JAK1JAK3TYK2ALOX5AP
SCHEMBL29922698 0.92 TYK2 (0.36) JAK2JAK1JAK3TYK2ALOX5AP
SCHEMBL28359021 0.92 TYK2 (0.36) JAK2JAK1JAK3TYK2ALOX5AP
SCHEMBL29552173 0.88 TYK2 (0.48) JAK2JAK1JAK3TYK2KDM1A
SCHEMBL28362626 0.87 JAK1 (0.49) JAK2JAK1JAK3TYK2RORC
SCHEMBL29553135 0.84 JAK2 (0.39) JAK2JAK1JAK3TYK2RORC
SCHEMBL28359066 0.83 TYK2 (0.49) JAK2JAK1JAK3TYK2KDM1A
SCHEMBL28359221 0.78 JAK3 (0.52) JAK2JAK1JAK3TYK2
SCHEMBL29552283 0.78 JAK2 (0.49) JAK2JAK1JAK3TYK2
SCHEMBL29922752 0.78 JAK2 (0.49) JAK2JAK1JAK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback